Danaher Co. (NYSE:DHR) Stock Position Raised by Profund Advisors LLC

Profund Advisors LLC lifted its holdings in shares of Danaher Co. (NYSE:DHR) by 10.2% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 18,022 shares of the conglomerate’s stock after buying an additional 1,666 shares during the period. Profund Advisors LLC’s holdings in Danaher were worth $2,766,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in DHR. Solstein Capital LLC bought a new position in Danaher in the 4th quarter worth about $422,000. BerganKDV Wealth Management LLC lifted its position in shares of Danaher by 474.5% in the 4th quarter. BerganKDV Wealth Management LLC now owns 2,752 shares of the conglomerate’s stock valued at $422,000 after acquiring an additional 2,273 shares in the last quarter. PFG Advisors lifted its position in shares of Danaher by 0.3% in the 4th quarter. PFG Advisors now owns 27,560 shares of the conglomerate’s stock valued at $4,307,000 after acquiring an additional 72 shares in the last quarter. Cleararc Capital Inc. lifted its position in shares of Danaher by 1.8% in the 3rd quarter. Cleararc Capital Inc. now owns 8,719 shares of the conglomerate’s stock valued at $1,259,000 after acquiring an additional 152 shares in the last quarter. Finally, Johanson Financial Advisors Inc. purchased a new stake in shares of Danaher in the 4th quarter valued at approximately $200,000. 79.72% of the stock is owned by institutional investors and hedge funds.

In related news, SVP William King sold 26,370 shares of the business’s stock in a transaction dated Thursday, February 20th. The shares were sold at an average price of $160.23, for a total value of $4,225,265.10. Following the transaction, the senior vice president now directly owns 22,427 shares of the company’s stock, valued at approximately $3,593,478.21. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Thomas Patrick Joyce, Jr. sold 132,474 shares of the business’s stock in a transaction dated Friday, January 31st. The stock was sold at an average price of $162.51, for a total transaction of $21,528,349.74. Following the completion of the transaction, the chief executive officer now directly owns 246,027 shares in the company, valued at $39,981,847.77. The disclosure for this sale can be found here. In the last three months, insiders sold 297,385 shares of company stock valued at $48,153,397. 11.40% of the stock is currently owned by insiders.

Several research firms have weighed in on DHR. JPMorgan Chase & Co. upped their price objective on shares of Danaher from $155.00 to $175.00 in a research note on Thursday, December 19th. Wells Fargo & Co assumed coverage on shares of Danaher in a report on Tuesday, January 7th. They issued an “overweight” rating and a $170.00 target price on the stock. Bank of America raised their price target on shares of Danaher from $165.00 to $188.00 and gave the stock a “buy” rating in a research report on Friday, January 31st. Robert W. Baird restated a “buy” rating and issued a $136.00 price target on shares of Danaher in a research report on Monday. Finally, Zacks Investment Research lowered shares of Danaher from a “hold” rating to a “sell” rating and set a $168.00 target price on the stock. in a research report on Tuesday, January 14th. One analyst has rated the stock with a sell rating, five have issued a hold rating and ten have issued a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average target price of $166.41.

Danaher stock traded up $9.34 during trading hours on Thursday, reaching $138.66. 5,268,591 shares of the stock were exchanged, compared to its average volume of 3,348,842. The company has a market cap of $89.92 billion, a P/E ratio of 34.24, a price-to-earnings-growth ratio of 2.14 and a beta of 0.96. The company has a current ratio of 5.19, a quick ratio of 4.86 and a debt-to-equity ratio of 0.75. Danaher Co. has a twelve month low of $119.60 and a twelve month high of $169.19. The stock has a 50 day moving average of $149.39 and a two-hundred day moving average of $147.49.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Thursday, January 30th. The conglomerate reported $1.28 earnings per share for the quarter, beating analysts’ consensus estimates of $1.25 by $0.03. The company had revenue of $4.87 billion for the quarter, compared to the consensus estimate of $4.80 billion. Danaher had a net margin of 15.09% and a return on equity of 11.50%. The firm’s quarterly revenue was up 5.7% compared to the same quarter last year. During the same period last year, the company posted $1.28 EPS. On average, analysts expect that Danaher Co. will post 5.38 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 24th. Stockholders of record on Friday, March 27th will be paid a $0.18 dividend. The ex-dividend date of this dividend is Thursday, March 26th. This represents a $0.72 annualized dividend and a dividend yield of 0.52%. This is a positive change from Danaher’s previous quarterly dividend of $0.17. Danaher’s payout ratio is currently 15.38%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments; Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.

Featured Story: Purposes and Functions of the Federal Reserve

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.